Side-by-side comparison: effects, dosing ranges, side effects, regulatory status, and reconstitution.
Peptide A
Sleep
Endogenous nonapeptide that promotes delta wave sleep and modulates neuroendocrine stress responses.
Peptide B
Cognitive
Neuroprotective ACTH analog with nootropic and neurotrophic properties.
Typical vial
5 mg
Typical dose
100-300 mcg
Half-life
~7-8 minutes (rapidly degraded by aminopeptidases)
FDA status
Not FDA approved for human use. No clinical trials submitted…
Typical vial
5 mg
Typical dose
200-600 mcg
Half-life
~2-3 minutes (very rapid degradation; biological effects last hours due to downstream gene expression changes)
FDA status
Not FDA approved for human use. Approved in Russia for strok…
DSIP effects
Semax effects
DSIP side effects
Semax side effects
DSIP dosing ranges
Sleep support
100-300 mcg · Once daily, 30-60 minutes before bedtime (SubQ) · 2-4 weeks
Stress and cortisol modulation
100-200 mcg · Once daily (SubQ) · 2-4 weeks
Semax dosing ranges
Cognitive enhancement
200-600 mcg · Once or twice daily (intranasal) · 10-20 days per course
Neuroprotection / stroke recovery
600-1200 mcg · Two to three times daily (intranasal) · 10-14 days
DSIP: Endogenous nonapeptide that promotes delta wave sleep and modulates neuroendocrine stress responses. Typical dose 100-300 mcg. Semax: Neuroprotective ACTH analog with nootropic and neurotrophic properties. Typical dose 200-600 mcg. Both fall under the Sleep and Cognitive categories.
Stacking DSIP with Semax is a protocol-design question best raised with a clinician — it depends on your goal, current bloodwork, and whether both peptides target overlapping mechanisms. Both peptides should be tracked independently with separate injection sites and timing. PinnyPeptide supports multi-peptide stacks with automatic injection site rotation.
DSIP is typically dosed: Once daily, 30-60 minutes before bedtime (SubQ) for Sleep support; Once daily (SubQ) for Stress and cortisol modulation. Semax is typically dosed: Once or twice daily (intranasal) for Cognitive enhancement; Two to three times daily (intranasal) for Neuroprotection / stroke recovery.
DSIP: Not FDA approved for human use. No clinical trials submitted for FDA review. Semax: Not FDA approved for human use. Approved in Russia for stroke recovery, cognitive impairment, and optic nerve disease.
Log doses, automate injection site rotation, and never lose track of where you last pinned. Free forever.
Get Started Free